NASAL SPRAY FORMULATION AND ANTI COVID-19 ORAL SPRAY ENGINEERED WITH LIPOSOMES

Programme 2014 - 2020 INTERREG V-A Italy - Switzerland

Date of latest update: 2024-03-27

Description

Description (IT):

Lo scopo del progetto è quello di ricercare, formulare, studiare e validare uno spray nasale e spray orale utile per la profilassi al COVID-19. Si selezioneranno alcuni estratti vegetali con proprietà antibatteriche e antivirali che si intendono ingegnerizzare: verranno infatti selezionate alcune molecole ed estratti vegetali che verranno formulate con olii auto emulsionanti per creare dei nanoliposomi che massimizzano l’assorbimento nelle membrane plasmatiche, nella mucosa nasale e mucosa orale. Inoltre, si studierà anche la possibilità di creare, con gli ingredienti del prodotto, un’ambiente con un Ph tale da inibire la crescita del virus.

Description (EN):

The aim of the project is to research, formulate, study and validate a nasal and oral spray useful for COVID-19 prophylaxis. Some plant extracts with antibacterial s and antivirals properties will be selected and engineered to maximize the absorption in plasma membranes, in nasal and oral mucosa. In addition it will also be studied the possibility of creating a Ph environemnt to inhibit the growth of the virus

Achievements (EN):

The ability to create links between research bodies and businesses has also allowed the development of responses and the testing of models to deal with the Covid-19 pandemic: with the third funding notice of the Programme, the development of specific solutions for the management of health emergencies, through projects such as SPRAY ANTICOVID-19, which has created a nasal and oral spray useful for Covid-19 prophylaxis, selecting some plant extracts with antibacterial and antiviral properties.

Website: http://interreg-italiasvizzera.eu/

Expected Results (IT):

Incremento del numero di strumenti di protezione nella lotta contro Covid-19 (+1 dispositivo Spray orale e + 1 dispositivo Spray nasale); Riduzione del rischio di contrarre nuove patologie respiratorie virali (compresa l’influenza stagionale) come da risultati test in vitro; Soddisfazione della comunità scientifica misurata attraverso apposita attività di valutazione effettuata nell’ambito delle attività di comunicazione attuate;

Expected Outputs (IT):

Produzione prototipale dei 2 dispositivi medici in SPRAY (uno ad uso orale e uno ad uso nasale) Dossier contenenti materiale messo a disposizione dei partecipanti agli eventi di comunicazione pubblica Studio contenente i risultati dell’analisi delle proprietà antivirali delle maggiori piante medicinali 2 Schede tecniche della formula non caratterizzata Studio sulla citotossicità dei composti

Thematic information

Health and social services

Specific Objective: Greater collaboration between businesses in the border area

Thematic Objective: (03) enhancing the competitiveness of SMEs by:

Investment Priority: (03b) developing and implementing new business models for SMEs, in particular with regard to internationalisation

Partners (3)

Lead Partner: VB Technochemicals SA

Address: chiasso, Switzerland

Legal status: private

Lead Partner: DGP PHARMA S.R.L.

Address: novara, Italy

Legal status: private

Total budget: EUR 175 650.00

ERDF budget: EUR 149 302.50

IBIS - INNOVATIVE BIO-BASED AND SUSTAINABLE PRODUCTS AND PROCESSES

Name: IBIS - INNOVATIVE BIO-BASED AND SUSTAINABLE PRODUCTS AND PROCESSES

Address: novara, Italy

Legal status: private

Total budget: EUR 75 214.50

ERDF budget: EUR 63 932.32

Partners map

Lead partner

Project partner

Summary

Project name (IT): FORMULAZIONE SPRAY NASALE E SPRAY ORALE ANTI COVID-19 INGEGNERIZZATO CON LIPOSOMI

Project name (EN): NASAL SPRAY FORMULATION AND ANTI COVID-19 ORAL SPRAY ENGINEERED WITH LIPOSOMES

Project acronym: SPRAY ANTI COVID-19

Project start date: 2022-05-16

Project end date: 2023-06-15

Project status: closed

Total budget/expenditure: EUR 250 864.50

Total EU funding (amount): EUR 213 234.82

Co-financing sources:

ERDF: Amount, EUR 213 234.82.

Information regarding the data in keep.eu on the programme financing this project

Financing programme

2014 - 2020 INTERREG V-A Italy - Switzerland

Last month that data in keep.eu was retrieved from the Programme's website or received from the Programme

2023-01-25

No. of projects in keep.eu / Total no. of projects (% of projects in keep.eu)

118 / 118 (100%)

No. of project partnerships in keep.eu / Total no. of project partnerships (% of project partnerships in keep.eu)

658 / 658 (100%)

Notes on the data

Information provided by the Programme. Achievements were retrieved by Interact from the Programme website (http://interreg-italiasvizzera.eu/), or a website directly linked from it, on 2021-11-23 and 2024-03-03.

Languages

Contact Form

NASAL SPRAY FORMULATION AND ANTI COVID-19 ORAL SPRAY ENGINEERED WITH LIPOSOMES

Description

Thematic information

Partners (3)

Partners map

Summary

Information regarding the data in keep.eu on the programme financing this project

Disclaimer